is there a shortage of glp 1 drugs GLP-1 No Longer on FDA's Drug List GLP-1 No Longer on FDA's
Description
Safe, drug-free, non-GMO, USA-made

95% CI: 0.8, 0.9

Looking for the best laxative for GLP-1 constipation

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

GLP-1 medications such as Ozempic may help lower the risk of certain cancers.
